U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Usher syndrome type 2

MedGen UID:
83288
Concept ID:
C0339534
Disease or Syndrome
Synonym: Usher Syndrome, Type II
SNOMED CT: Usher syndrome type 2 (232058008)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
 
Monarch Initiative: MONDO:0016484
Orphanet: ORPHA231178

Disease characteristics

Excerpted from the GeneReview: Usher Syndrome Type II
Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families. [from GeneReviews]
Authors:
Robert Koenekoop  |  Moises Arriaga  |  Karmen M Trzupek, et. al.   view full author information

Additional description

From MedlinePlus Genetics
Usher syndrome type II is characterized by hearing loss from birth and progressive vision loss that begins in adolescence or adulthood. The hearing loss associated with this form of Usher syndrome ranges from mild to severe and mainly affects the ability to hear high-frequency sounds. For example, it is difficult for affected individuals to hear high, soft speech sounds, such as those of the letters d and t. The degree of hearing loss varies within and among families with this condition, and it may become more severe over time. Unlike the other forms of Usher syndrome, type II is not associated with vestibular abnormalities that cause difficulties with balance.

Most individuals with Usher syndrome type I are born with severe to profound hearing loss. Worsening vision loss caused by retinitis pigmentosa becomes apparent in childhood. This type of Usher syndrome also causes abnormalities of the vestibular system, which is the part of the inner ear that helps maintain the body's balance and orientation in space. As a result of the vestibular abnormalities, children with the condition have trouble with balance. They begin sitting independently and walking later than usual, and they may have difficulty riding a bicycle and playing certain sports.

Researchers have identified three major types of Usher syndrome, designated as types I, II, and III. These types are distinguished by the severity of hearing loss, the presence or absence of balance problems, and the age at which signs and symptoms appear. The types are further divided into subtypes based on their genetic cause.

Usher syndrome is a condition characterized by partial or total hearing loss and vision loss that worsens over time. The hearing loss is classified as sensorineural, which means that it is caused by abnormalities of the inner ear. The loss of vision is caused by an eye disease called retinitis pigmentosa (RP), which affects the layer of light-sensitive tissue at the back of the eye (the retina). Vision loss occurs as the light-sensing cells of the retina gradually break down. Loss of night vision begins first, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. In some cases, vision is further impaired by clouding of the lens of the eye (cataracts). However, many people with retinitis pigmentosa retain some central vision throughout their lives.

People with Usher syndrome type III experience hearing loss and vision loss beginning somewhat later in life. Unlike the other forms of Usher syndrome, type III is usually associated with normal hearing at birth. Hearing loss typically begins during late childhood or adolescence, after the development of speech, and becomes more severe over time. By middle age, most affected individuals have profound hearing loss. Vision loss caused by retinitis pigmentosa also develops in late childhood or adolescence. Some people with Usher syndrome type III develop vestibular abnormalities that cause problems with balance.  https://medlineplus.gov/genetics/condition/usher-syndrome

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Professional guidelines

PubMed

Stephenson KAJ, Whelan L, Zhu J, Dockery A, Wynne NC, Cairns RM, Kirk C, Turner J, Duignan ES, O'Byrne JJ, Silvestri G, Kenna PF, Farrar GJ, Keegan DJ
Invest Ophthalmol Vis Sci 2023 Jul 3;64(10):23. doi: 10.1167/iovs.64.10.23. PMID: 37466950Free PMC Article
Lear SA, Gasevic D
Nutrients 2019 Dec 19;12(1) doi: 10.3390/nu12010015. PMID: 31861719Free PMC Article
Samanta A, Stingl K, Kohl S, Ries J, Linnert J, Nagel-Wolfrum K
Int J Mol Sci 2019 Dec 12;20(24) doi: 10.3390/ijms20246274. PMID: 31842393Free PMC Article

Recent clinical studies

Etiology

Micevych PS, Wong J, Zhou H, Wang RK, Porco TC, Carroll J, Roorda A, Duncan JL
Am J Ophthalmol 2023 Jun;250:1-11. Epub 2023 Jan 14 doi: 10.1016/j.ajo.2023.01.006. PMID: 36646238Free PMC Article
Lad EM, Duncan JL, Liang W, Maguire MG, Ayala AR, Audo I, Birch DG, Carroll J, Cheetham JK, Durham TA, Fahim AT, Loo J, Deng Z, Mukherjee D, Heon E, Hufnagel RB, Guan B, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Vincent A, Weng CY, Farsiu S; Foundation Fighting Blindness Consortium Investigator Group
Am J Ophthalmol 2022 Dec;244:98-116. Epub 2022 Aug 22 doi: 10.1016/j.ajo.2022.08.013. PMID: 36007554Free PMC Article
Gill JS, Theofylaktopoulos V, Mitsios A, Houston S, Hagag AM, Dubis AM, Moosajee M
Int J Mol Sci 2022 Apr 11;23(8) doi: 10.3390/ijms23084198. PMID: 35457016Free PMC Article
Ehn M, Anderzén-Carlsson A, Möller C, Wahlqvist M
Int J Qual Stud Health Well-being 2019 Dec;14(1):1656790. doi: 10.1080/17482631.2019.1656790. PMID: 31470768Free PMC Article
García-García G, Besnard T, Baux D, Vaché C, Aller E, Malcolm S, Claustres M, Millan JM, Roux AF
Mol Vis 2013;19:367-73. Epub 2013 Feb 13 PMID: 23441107Free PMC Article

Diagnosis

Micevych PS, Wong J, Zhou H, Wang RK, Porco TC, Carroll J, Roorda A, Duncan JL
Am J Ophthalmol 2023 Jun;250:1-11. Epub 2023 Jan 14 doi: 10.1016/j.ajo.2023.01.006. PMID: 36646238Free PMC Article
Lad EM, Duncan JL, Liang W, Maguire MG, Ayala AR, Audo I, Birch DG, Carroll J, Cheetham JK, Durham TA, Fahim AT, Loo J, Deng Z, Mukherjee D, Heon E, Hufnagel RB, Guan B, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Vincent A, Weng CY, Farsiu S; Foundation Fighting Blindness Consortium Investigator Group
Am J Ophthalmol 2022 Dec;244:98-116. Epub 2022 Aug 22 doi: 10.1016/j.ajo.2022.08.013. PMID: 36007554Free PMC Article
Gill JS, Theofylaktopoulos V, Mitsios A, Houston S, Hagag AM, Dubis AM, Moosajee M
Int J Mol Sci 2022 Apr 11;23(8) doi: 10.3390/ijms23084198. PMID: 35457016Free PMC Article
Toms M, Dubis AM, de Vrieze E, Tracey-White D, Mitsios A, Hayes M, Broekman S, Baxendale S, Utoomprurkporn N, Bamiou D, Bitner-Glindzicz M, Webster AR, Van Wijk E, Moosajee M
Hum Mol Genet 2020 Jul 21;29(11):1882-1899. doi: 10.1093/hmg/ddaa004. PMID: 31998945Free PMC Article
Vezinaw CM, Fishman GA, Chiang J
Doc Ophthalmol 2019 Apr;138(2):161-166. Epub 2019 Feb 22 doi: 10.1007/s10633-019-09677-8. PMID: 30796641

Therapy

Gill JS, Theofylaktopoulos V, Mitsios A, Houston S, Hagag AM, Dubis AM, Moosajee M
Int J Mol Sci 2022 Apr 11;23(8) doi: 10.3390/ijms23084198. PMID: 35457016Free PMC Article
Toms M, Dubis AM, de Vrieze E, Tracey-White D, Mitsios A, Hayes M, Broekman S, Baxendale S, Utoomprurkporn N, Bamiou D, Bitner-Glindzicz M, Webster AR, Van Wijk E, Moosajee M
Hum Mol Genet 2020 Jul 21;29(11):1882-1899. doi: 10.1093/hmg/ddaa004. PMID: 31998945Free PMC Article
Vaché C, Besnard T, le Berre P, García-García G, Baux D, Larrieu L, Abadie C, Blanchet C, Bolz HJ, Millan J, Hamel C, Malcolm S, Claustres M, Roux AF
Hum Mutat 2012 Jan;33(1):104-8. Epub 2011 Nov 16 doi: 10.1002/humu.21634. PMID: 22009552
Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL
Invest Ophthalmol Vis Sci 2011 Apr 6;52(5):2219-26. doi: 10.1167/iovs.10-6479. PMID: 21087953Free PMC Article

Prognosis

Reurink J, Oostrik J, Aben M, Ramos MG, van Berkel E, Ołdak M, van Wijk E, Kremer H, Roosing S, Cremers FPM
Int J Mol Sci 2022 Nov 1;23(21) doi: 10.3390/ijms232113343. PMID: 36362125Free PMC Article
Birch DG, Cheng P, Duncan JL, Ayala AR, Maguire MG, Audo I, Cheetham JK, Durham TA, Fahim AT, Ferris FL 3rd, Heon E, Huckfeldt RM, Iannaccone A, Khan NW, Lad EM, Michaelides M, Pennesi ME, Stingl K, Vincent A, Weng CY; Foundation Fighting Blindness Consortium Investigator Group
Transl Vis Sci Technol 2020 Oct;9(11):9. Epub 2020 Oct 8 doi: 10.1167/tvst.9.11.9. PMID: 33133772Free PMC Article
He C, Liu X, Zhong Z, Chen J
BMC Ophthalmol 2020 Feb 24;20(1):70. doi: 10.1186/s12886-020-01342-y. PMID: 32093671Free PMC Article
Vezinaw CM, Fishman GA, Chiang J
Doc Ophthalmol 2019 Apr;138(2):161-166. Epub 2019 Feb 22 doi: 10.1007/s10633-019-09677-8. PMID: 30796641
Zong L, Chen K, Wu X, Liu M, Jiang H
Int J Pediatr Otorhinolaryngol 2016 Nov;90:150-155. Epub 2016 Sep 12 doi: 10.1016/j.ijporl.2016.09.010. PMID: 27729122

Clinical prediction guides

Schellens RTW, Slijkerman RWN, Hetterschijt L, Peters TA, Broekman S, Clemént A, Westerfield M, Phillips JB, Boldt K, Kremer H, De Vrieze E, Van Wijk E
J Proteomics 2022 Aug 30;266:104666. Epub 2022 Jul 2 doi: 10.1016/j.jprot.2022.104666. PMID: 35788411
Gill JS, Theofylaktopoulos V, Mitsios A, Houston S, Hagag AM, Dubis AM, Moosajee M
Int J Mol Sci 2022 Apr 11;23(8) doi: 10.3390/ijms23084198. PMID: 35457016Free PMC Article
Toms M, Dubis AM, de Vrieze E, Tracey-White D, Mitsios A, Hayes M, Broekman S, Baxendale S, Utoomprurkporn N, Bamiou D, Bitner-Glindzicz M, Webster AR, Van Wijk E, Moosajee M
Hum Mol Genet 2020 Jul 21;29(11):1882-1899. doi: 10.1093/hmg/ddaa004. PMID: 31998945Free PMC Article
Vezinaw CM, Fishman GA, Chiang J
Doc Ophthalmol 2019 Apr;138(2):161-166. Epub 2019 Feb 22 doi: 10.1007/s10633-019-09677-8. PMID: 30796641
Zong L, Chen K, Wu X, Liu M, Jiang H
Int J Pediatr Otorhinolaryngol 2016 Nov;90:150-155. Epub 2016 Sep 12 doi: 10.1016/j.ijporl.2016.09.010. PMID: 27729122

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...